AMSBIO has implemented a program of investment to support the students at Penn State Lehigh Valley, part of Pennsylvania State University, in their transformative Course-based Undergraduate Research Experience (CURE) program.
UK contract development and manufacturing organisation (CDMO) Upperton, continues its growth with the appointment of Lorna Patrick as chief operating officer.
The Gabriel-Chemie Group has announced the opening of a new warehouse that will now serve as the central logistics hub for the entire Gabriel-Chemie group.
NeoPhore, a small molecule neoantigen immuno-oncology company, has announced the appointment of Michael Shih as chief executive officer (CEO) and to the board of directors, effective immediately.
Investors worldwide are scouring for their next big win after the door to the extremely lucrative obesity market was opened by pharmaceutical giants Novo Nordisk and Eli Lilly. Now benefiting on the Swedish stock exchange is a smaller biotech company
Gerresheimer announces that the US Food and Drug Administration (FDA) granted SQ Innovation Tentative Approval for Lasix ONYU for the home treatment of fluid overload in congestive heart failure.
Without aligned process improvements across Regulatory Affairs, Quality and Pharmacovigilance/Drug Safety, pharma companies risk limiting their overall market performance, says MAIN5’s Tobias Hitziger.
The ENGEL Group subsidiary, TMA AUTOMATION Sp. z o.o., has begun construction of a modern office and production building in the immediate vicinity of Gdansk Airport in Poland.
